We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+4.44%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$28.3B
AUM Growth
+$2.33B
(+9%)
Cap. Flow
+$1.79B
Cap. Flow
% of AUM
6.32%
Top 10 Holdings %
Top 10 Hldgs %
25.96%
Holding
1,069
New
128
Increased
377
Reduced
389
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$356M |
| 2 |
Lam Research
LRCX
|
+$283M |
| 3 |
Palo Alto Networks
PANW
|
+$261M |
| 4 |
GE Vernova
GEV
|
+$216M |
| 5 |
Tractor Supply
TSCO
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$275M |
| 2 |
Intuit
INTU
|
+$214M |
| 3 |
CrowdStrike
CRWD
|
+$204M |
| 4 |
Williams-Sonoma
WSM
|
+$164M |
| 5 |
Old Dominion Freight Line
ODFL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.61% |
| 2 | Financials | 14.28% |
| 3 | Consumer Discretionary | 13.77% |
| 4 | Industrials | 12.88% |
| 5 | Healthcare | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
CSX Corp
CSX
$94.2B
| $280K | ﹤0.01% |
8,687
+2,568
| +42% | +$88.1K |
|
|
KLRS
877
Kalaris Therapeutics
KLRS
$79.5M
| $279K | ﹤0.01% |
+28,888
| New | +$437K |
|
878
Tilly's
TLYS
$118M
| $278K | ﹤0.01% |
65,440
-47,849
| -42% | -$195K |
|
|
MRC
879
DELISTED
MRC Global
MRC
| $274K | ﹤0.01% |
21,464
| – | – |
|
880
Ovid Therapeutics
OVID
$440M
| $272K | ﹤0.01% |
+291,701
| New | +$326K |
|
881
Old Second Bancorp
OSBC
$1.3B
| $268K | ﹤0.01% |
+15,100
| New | +$262K |
|
882
Sight Sciences
SGHT
$288M
| $264K | ﹤0.01% |
72,625
-135,268
| -65% | -$616K |
|
883
HCI Group
HCI
$2.29B
| $255K | ﹤0.01% |
+2,191
| New | +$250K |
|
884
United Natural Foods
UNFI
$3.07B
| $247K | ﹤0.01% |
9,026
-219,653
| -96% | -$5.06M |
|
885
AMC Global Media
AMCX
$451M
| $246K | ﹤0.01% |
24,877
-1,760
| -7% | -$15.6K |
|
886
FedEx
FDX
$74B
| $246K | ﹤0.01% |
+875
| New | +$244K |
|
887
Polaris
PII
$4.07B
| $242K | ﹤0.01% |
+4,208
| New | +$293K |
|
888
Metagenomi Therapeutics
MGX
$45.6M
| $239K | ﹤0.01% |
66,182
-70,442
| -52% | -$170K |
|
889
CNX Resources
CNX
$4.84B
| $235K | ﹤0.01% |
6,416
| – | – |
|
890
StepStone Group
STEP
$3.65B
| $231K | ﹤0.01% |
3,995
| – | – |
|
891
Lincoln National
LNC
$8.19B
| $229K | ﹤0.01% |
7,208
-78,560
| -92% | -$2.62M |
|
892
Tiptree Inc
TIPT
$678M
| $228K | ﹤0.01% |
10,919
| – | – |
|
893
eBay
EBAY
$52.1B
| $226K | ﹤0.01% |
3,654
-814,687
| -100% | -$51.8M |
|
894
CNB Financial Corp
CCNE
$1.05B
| $219K | ﹤0.01% |
+8,805
| New | +$230K |
|
|
SCHW
895
Charles Schwab
SCHW
$184B
| $219K | ﹤0.01% |
2,957
-93,620
| -97% | -$7.01M |
|
|
896
Williams-Sonoma
WSM
$27.8B
| $216K | ﹤0.01% |
1,168
-1,035,088
| -100% | -$164M |
|
897
Radiant Logistics
RLGT
$411M
| $208K | ﹤0.01% |
31,072
-1,420
| -4% | -$9.78K |
|
898
Orange County Bancorp
OBT
$521M
| $206K | ﹤0.01% |
+7,428
| New | +$214K |
|
899
Resideo Technologies
REZI
$5.55B
| $201K | ﹤0.01% |
8,726
-39,960
| -82% | -$937K |
|
900
Hewlett Packard
HPE
$60.4B
| $201K | ﹤0.01% |
+9,418
| New | +$199K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2024 Portfolio in Review
As of Q4 2024, Jacobs Levy Equity Management held 1,069 positions worth $28.3B, up 9% from $25.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jacobs Levy Equity Management deployed $1.79B of net new capital in Q4 2024, opening 128 new positions and adding to 377 existing holdings. Its largest new stake was Tractor Supply: 2,947,687 shares worth $156M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Amphenol, an estimated $275M trimmed.
- Jacobs Levy Equity Management's largest Q4 2024 buy was Tractor Supply: 2,947,687 shares worth $156M.
- Jacobs Levy Equity Management added most to Arista Networks in Q4 2024, an estimated $356M increase.
- Jacobs Levy Equity Management's biggest Q4 2024 reduction was Amphenol, cutting an estimated $275M.
- Jacobs Levy Equity Management fully exited Sarepta Therapeutics in Q4 2024, selling an estimated $94.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 26% of its $28.3B portfolio in Q4 2024.
- Jacobs Levy Equity Management opened 128 new positions and closed 143 in Q4 2024.
- Jacobs Levy Equity Management's portfolio value rose 9% quarter-over-quarter to $28.3B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2024, filed 14 Feb 2025.